One distinctive aspect of the response to acute inflammation involves a rapid and persistent decrease in the numbers of circulating eosinophils, yet the mechanisms of this eosinopenia are undefined. One possibility is that the abrupt eosinopenia may be the result of release of small amounts of the chemotactic factors of acute inflammation into the circulation. These studies were designed to examine the numbers of circulating eosinophils after an intravenous injection of zymosan-activated serum, partially purified C5a or the synthetic peptide, N-formyl-methionyl-leucyl-phenylalanine. Each of these factors caused a virtual disappearance of circulating eosinophils within 1 min, a transient return of eosinophils tõ 50% of control levels after 10-90 min, and a subsequent decrease which persisted for 5 h. In contrast, the numbers of circulating heterophils, although dropping transiently, rapidly returned and rose to elevated levels for 6 h after injection. The response was not caused by adrenal mediation as it occurred normally in adrenalectomized rabbits. Two chemotaxins of allergic inflammation, histamine and the tetrapeptide valine-glycine-serine-glutamic acid, did not cause significant eosinopenia.
A B S T R A C T One distinctive aspect of the response to acute inflammation involves a rapid and persistent decrease in the numbers of circulating eosinophils, yet the mechanisms ofthis eosinopenia are undefined. One possibility is that the abrupt eosinopenia may be the result of release of small amounts of the chemotactic factors ofacute inflammation into the circulation. These studies were designed to examine the numbers of circulating eosinophils after an intravenous injection of zymosan-activated serum, partially purified C5a or the synthetic peptide, N-formyl-methionyl-leucyl-phenylalanine. Each of these f:actors caused a virtual disappearance of circulating eosinophils within 1 min, a transient returrn ofeosinophils to -50% of control levels after 10-90 min, and a subsequient decrease which persisted for 5 h. In contrast, the numbers of circulating heterophils, although (dropping transiently, rapidly returined and rose to elevated levels for 6 h after injection. The response was not caused by adrenal mediation as it occurred normally in adrenalectomized rabbits. Two chemotaxins of' allergic inflamm-llationi, histamine and the tetrapeptide valine-glycine-serineglutamic acid, did not cause significant eosinopenia.
Circulating granulocytes of patients undergoing hemodialysis, which has been reported to activate complement, demonstrated similar eosinopenic and neutropenic-neutrophilic responses. Thus, in rabbits and in man, intravascular activation or injection of chemotactic factors (C5a orN-formyl-methionyl-leucylphenylalanine) causes a brief, nonspecific granulocytopenia followed by a prolonged eosinopenic-neutrophilic response analogous to that seen during acute infection.
INTRODUCTION
Eosinopenia and neutrophilia typically accompany the responses to acute stress or acute infection. These responses are among the most dramatic examples of the differential regulation of the eosinophil and neutrophil leukocyte series, yet the mechanisms are inadequately understood. The eosinopenia of acute stress involves mediation by adrenal glucocorticosteroids and epinephrine (1, 2) . The eosinopenia that occurs during acute inflammatory states is not dependent upon these endocrine mechanisms (3), but the causes are not well defined.
In previous studies similar eosinopenic responses followed the induction of acute inflammation by diverse bacterial, viral, and chemical irritant stimuli (4). These studies suggested that the eosinopenia represented a response to the acute inflammatory process itself or to some systemic reaction induced by it. Further studies examined whether substances in the acute inflammatory exudate might mediate an eosinopenic reaction. Acute inflammatory exudate, obtained after pneumococcal infection of a subcutaneous air pouch in mice, was found to contain a material capable of causing eosinopenia when injected intraperitoneally into eosinophilic mice (5) . Partial characterization of this substance suggested that it was a large molecular weight glycoprotein. This material produced an eosinopenic response which was apparent between 4 and 20 h after intraperitoneal injection. Eosinopenic activity was detectable in the exudate 10 h after inoculation of pneumococci and reached its highest concentration 20 h after inoculation. Thus, this eosinopenic activity seemed to appear rather -Mte in the inflammatory exudate. It was suggested that this substance may Nwhich normially persists throughout the period of active actute inflaimmation; However, this material could niot explaiin the initial, abrupt eosiniopeniia which followed the inidtuction of an acute inflamnmiiatory process (4) .
The initial eosinopenic response to acute inflammation was interpreted as being the result of a rapid peripheral sequestration of circulating eosinophils (3, 4) . The sites of sequestration were uncertain. It was not due to entrapment of eosinophils within the spleen or lymph nodes. Part of the sequestration could be ascribed to mnigration of eosinophils into the inflammatorv site itself, presumably by the chemotactic substances released during acute inflammilation. Several of the major chemotactic substances of acute inflammation, including C5a (6), the complex C567 (7) , fibrin fragments (8) , and N-formvl-methionyl peptides (used by I many investigators as synthetic analogues of bacterial chemiiotactic factors) (9) are chemotactic in vitro for eosinophils as well as neutrophils. The presence of such chemotactic factors, in particular C5a, has been detected in the circulation during acute inflammatory states (10, 11) . The question arises whether release into the circulation of small amounts of the chemotactic factors of actute inflammation might contribute to the eosinopeniia of acute infectioin. The effects of such substances oni circulating neutrophils have recently been studied in somne detail. Intravascular activation of comiiplemenit in rabbits (12) or manl (13) or intravenous injectioin of substances chemotactic for neutrophils (12, 14) in rabbits pro(duce ain abrupt neutropenia wvithin a mmin which is followed by a neutrophilia which occurs after 30-90 min and lasts for several hours. The presenit studies examined the responses of circulating eosinophils to intravenouis injectioin of suclh cheImlotactic factors of acute inflamimation.
NIETHODS
Animiials. Newr Zealand white rabbits, young adult male wNeighing 2-4 kg, were obtained from Franklin's Rabbitrv, Wake Forest, N. C. Adrenalectomiiized New Zealand white rabbits were obtained from Dutchland Laboratories, Inc., Dtitchlancd Laboratory Animals, Inc., Denver, Pa. Adequacy ofthe adrenalectomiiies was determined by lack of eosinopenic responses to mild stress (repeated blood sampling) and to ACTH. In certain experimiients rabbits were rendered mildly eosinophilic by infection with trichinosis. Miuscle-stage larvae of Tric litnella .spiralis were obtained by acid-pepsin digestion of infected rat musculoskeletal tissues as previously described (15) . Rabbits were anesthetized with ketamiine (Bristol Laboratories, Syracuse-N. Y.) and xvlasine (Haver-Lockhart Labs., Shawnee Mission, Kan.), intubated with a pediatric feeding tube and inoculated orally with 10,000 infective larvae. After [3] [4] wk such rabbits wvere found to have a modest eosinophilia, wvith a meani eosinophil coUn1t of 323/mm1113. Blood samnpling anid rabbit grant locijte coon ts. Putative stimuli were injected into an ear vein. Blood samples were draxwn at timed intervals from a veil) of the opposite ear. Absolute eosinophil counts employed a counting fluid containing 50 g urea and 10 ml 2% eosin/100 ml a(queous solution (16) . Counting chambers were held in moist petri dishes for 30 min, which allowed lysis of the heterophils and bright staining of eosinophils. Total leukocyte counts and differential counts of Wright's stained smears allowed quantitation of the total granulocytes. Preliminary experiments examined the correlatioin of absolute eosinophil counts obtained with the above counting fluid with eosinophils determined by the less accurate method of a 200-cell differential count times the total leukocyte count. The two methods for determining the number of circulating eosinophils (absolute eosinophil count vs. total cell count x percent of eosinophils) demonstrated a correlation coefficient of0.94 with a slope of 1.1, nl = 16.
Stimulli. Zymosan-activated rabbit serum (ZAS)l was prepared by incubating 2 ml of fresh rabbit serum with 50 mg twice-washed zymosan (Schwarz/Mann Div., Becton, Dickinson & Co., Orangeburg, N. Y.) at 37°C for 30 min, with removal of the zymosan by centriftigation at 1,000 g for 10 min. N-formyl-methioiinl-leucvl-phenylalanine (fMLP [Andrulis Chemical Corp., Bethesda, Md.]) was dissolved in 0.02 NI NaHCO3 at 1 mg/ml and diluted to desired conicentrations in phosphate-buffered saline (PBS). Histamine phosphate (Fisher Scientific Co., Pittsburgh, Pa.) and the eosinophil chemotactic tetrapeptide valine-glycine-serine-glutamic acid (kindly provided by Dr. Ed. Goetzl, Harvard Mledical School, Boston, Mass.) vere dissolved in PBS anid adljusted to pH 7.4. Preparationi of partiallyJ purified C5a. 300 ml of fresh human serum was activated by incubation for 30 min with 50 g/liter zvmosan in the presenice of 1 MI E-aminocaproic acid. Preliminary experiments demonstrated that this incubation provided a maximal concentration of C5a (data not shown). C5a was partially purified by a modification of the method of Fernandez and Hugli (17) . During purification, the presence of C5a was assayed by the ability of the fraction to stimulate the uptake of [3H]deoxyglucose by normal human neutrophils (18) . The activated serum was adjusted to pH 3.8 with 1 M HCI and EDTA was added to a final concentration of 10 mM. All further procedures were conducted at 4°C. The activated serum was dialyzed in small pore tubing (Spectrapor 1, Spectrumii Medical Industries, Inc., Los Angeles, Calif.) against 0.1 M ammonium formate at pH 5.0 containing 0.5 mn\ EDTA unltil the concenitration of E-amiuiocaproic acidl was <1 mM. The dialyzed serumii was appliedl to 6 x 7-cll) columni of CNIcellulose; the coluIImnii was washle(d with 0.1 M formate, pH 5.0, ancd elutedl with 350 ml of 0.5 MI ammiiiioniium formate at pH 5.0. The elutedl material was then coi)celetrated by ultrafiltration (UM-10, Amicon Corp., Lexington, Mlass.) to a 28-ml volume. The material vas fractionated on a 2.6 x 95-cm Sephadex G-100 column equilibrated and eluted with 0.1 MI ammonium formate at pH 5.0 al)d a flow rate of 12 ml/h. 6-ml fractions were collected. The active fractions were pooled and the C5a activity confirmed by stimulation of chemotaxis in the chemotaxis-under-agarose assay modified as described previously (19) . The pooled fractions (termed "crude C5a") contained six bands by polyacrvlamide gel electrophoresis. The concentration of the preparation was adjusted to provide bioactivity (stimulation of chemotaxis and deoxyglucose uptake) equal to that of ZAS. A low molecular weight fraction, beyond the resolution of the Sephadex G-100 columnn and lacking activity in the [3H]deoxyglucose assay, wvas used as a control preparation).
Circuilatinig graimuloct tes in patients during hemodialilsis.
Patients with chronic ren)al failure, on maintenance hemo-1 Abbreviationis used in this paper: ECF-A, eosiinophil chemotactic factor of anaphylaxis; f NILP, N-formvl-methionylleucyl-phenylalanine; PBS, phosphate-buffered saline; ZAS, zym1osan-activated serunm.
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Bass, GonCwa, Szejda, Cauisart, DeChatelet, atnd McCall dialysis using a Cordis-Dow artificial kidney (hollow cellulose fiber), and( not taking corticosteroi(d or imnmnlliiosuppressive agents, w%ere examinie(l. Just hefore, andcl timed at intervals after the onset of dialvsis, bloo1( samnples were dIrawni from the afferent blood line of the dialysis circuit. Absolute eosinophil counts were performiied by Discombe's imiethod (20) . Total leukocvte couniits anid dlifferenitiall counits by WVright's stain were uisedl to determinie the numhers of circtulatinig neutrophils.
Statistical ataltysis. The variability of the eosiniophil couints at the beginning of the experimlenits necessitated expressioni of the circulatinig eosi nophil aindl heterophil coulnts as perceint of control, the count at the beginning of the experimiienits. Each experimiienit was repeatedl three to eight timiies with siimilar resiults. Significaniee was exaitnilied hv the unpaire(l Stuldenit's t test.
RESULTS
Effect ofZAS. Injection of ZAS produced anl abrupt drop in the numiiber of circulatinig eosinophils (Fig. 1) . Within 1 mni after injection, the eosinophils had fallen to zero. Between 20 and 60 mnii later the eosinophils againi appeared in the circulatioi onily to decrease in number with a biphasic response which was observed in every animilal examined. The timinig of this responise varied among animals such that the peak occurred betweenl 20 aind 90 min after injection. This is the reasoni for the large standard errors observed dturing this phase of the response. Because of this variability, attempts to average all of the responses resulted in a blurring of observations which, although they occuirred at slightly different times after stimulation, were consistently observed. For this reasoin the remainder of the data is presented in the formii of representative experiments rather thalin meaniis of observations. It slhould(l be emphasized that the observations reported were seen in every animal injected. Whereas the eosiniophils demiionstrated a biphasic response with a persistenit eosiniopeniia lastinig for 3-5 h, the heteroplhils, altlhough dropping immlledliately after injectioni, rose to control levels wvithin 20-60 mIi anid then proceededl to significaint elevations (ranige of 122-181% of control after 3 h) (Fig. 1) .
The eosinopenici responise to ZAS was not meediate(d bNy stimtulationi of release of corticosteroids. A 2-miig hy-(drocortisonie injectioni didI not prodltlce a signlificant eosinlopeinia unltil 2-4 h after injectioni, and(I at that timiie, produced an eosiniopeniia with a miieani of 48%. This is comparable to the eosiniopeniic responise reporte(l previously in other animlals and mlan (1, 2) . Moreover, the responses to ZAS were if anythinig more striking in rabbits which had been adrenialectomiiized (data not showni).
Dose-responise curves are shown in Fig. 2 . A signiificant dlecrease in the number of circulating eosiniophils and heterophils occurre(l 1 min after a 0.5-mll injectioll of ZAS. There was no significant difference in the sensitivity of the eosiniophils or heterophils to induiction of this initial abrupt response to ZAS.
Partially purified humlani C5a prodluced a simiiilar rapid (Irop in the number of circulatinig eosiniophils and heterophils (Fig. 3) . Fractionis fromii the same columiin lacking C5a activity did not produce a signiificant drop in either eosinophils or heterophils. P-odtuctioni of eo.sitope'a1ia i)laPll (it-iitng heit)odiali.sis. It has been reported that hemodialysis is associated witlh activationi of comiiplemiient by the dialysis mnemiibranie and that this is associated with a neutropenia-nieutrophilia response similar to the heterophil responses in rabbits after a ZAS injectioni (13) . Fig. 4 shows the miieani of observations on eight patienits in whom we observed the reported changes in neutrophils and found that this was accomiipanied by a similar degree of eosiniopenia. -Moreover, the eosinophil counts followed a course similar to that observed in the rabbits after injection of ZAS. Whereas the neutrophils rose to elevated levels between 60 and 300 min (the end of dialysis), the eosinophils remained reduced in numbers throughout the dialysis period.
The eosinopenic effect of fMLP. fMLP is chemotactic for neutrophils in the range of 10-4-10-6 mg/Mil. Injection of 10 ug of fMLP into rabbits with roughly 100 ml blood volume reduced the eosinophil count to zero within 1 min (Fig. 5 ). Moreover the eosinophils did not begin to appear until after 3 h and remained markedly depressed for the entire 5-h of observation. A 1-gg fMLP injection produced a biphasic eosinopenic response very similar to that observed after a ZAS injection (Fig. 5 ). The heterophil response to this dose of fMLP was very brief and rapidly proceeded Effects of histacmine, Eosinophil chemnotactic factor ofanaphylaxis (ECF-A), PBS or injectioni ofTrichinella larvae into immune animncals. The following experiments were performed to determine whether the eosinopeniic responses to ZAS and fMLP might represent a secondary manifestation of mast cell or Ed by the original D normal rabbits was DISCUSSION transient drop in the Of the numerous chemotactic substances released )hils ( Fig. 7 ). 1-ml during acute inflammation, the active substance in ZAS ne did not produce a (presumably C5a [6] ) and the peptide fMLP have been en though the highest extensively employed to examiiine the diverse biologic to cause significant effects of the chemotactic factors of actute inflainmation. iifested by wheezing The present studies demonstrated that injection of :F-A peptide Val-Gly-small quantities of such chemotactic factors into rabbits roduce any greater produced an eosinopenic response that was immediate, after a PBS injection. that was biphasic, and that produced eosinopenia elevated levels of which persisted for 5 h after a single injection of ive passive cutaneous stimulant. Partially purified C5a also prodtuced an should have mast cell eosinopenic response. Finally, study of patients (posure to trichinella undergoing hemodialysis, which also causes comipleof 10,000 trichinella ment activation (13) , revealed a similar eosinopenic ich caused moderate response. vithin 10-30 min and Eosinophils disappeared from the circulation within s along with eosino-1 min. This strongly suggests a direct effect on the a not shown), did not eosinophils and was probably caused by diffuse ic response. Further margination or sequestration of the cells within an the eosinopenia of organ such as the lung. For example, such sequestration jection with 0.4 mg/kg of neutrophils within the lung has been reported to Moreover, this also follow intravascular complement activation or injection f ECF-A but did not of activated serum (13, 14) . However, the distinctive ata not shown). As the responses of eosinophils and heterophils occurred may also be blocked after the initial phase of granulocyte sequestration. (21, 22) , it is probable Both granulocytes reappeared in the blood 10-90 PBS was caused by min after chemotaxin injection but, whereas circulating system during the heterophiles continued to increase and remained elevated for several hours, the eosinophils again decreased in number and remained so for the 5-h observation period. As these observations were made Val-Gly-Ser-GIu in vivo, it is impossible to determine whether this I pM second phase of the eosinopenic response was the result of a direct effect of the chemotaxin injection on the eosinophils. Two other mechanisms also 10pM 100pM deserve consideration. These include the release of eosinopenia-producing substances by neutrophils or mast cells. Exposure of surface-adherent or cytochalasin B-treated neutrophils to chemotactic factors in vitro causes stimulation of oxidative metabolic * PBS responses (23, 24) and degranulation (25, 26) . Such responses in vivo (e.g., during pulmonary sequestration) could cause release of substances chemotactic for eosinophils which might then cause local margination of eosinophils and thereby cause continued eosinopenia. In particular, the possible release of 0 10 20 30 neutrophil-derived eosinophil chemotactic factor (27) in) could be involved. This hypothesis remains to be tested. injection or varying Injection of this stimulatory material might also ,CF-A peptide, Val-Glycause mast cell or basophil degranulation, again with o0 trichinella larvae into resultant local sequestration of eosinophils. Either s of three experiments C5a (28) or fMLP (29) can cause degranulation of of two closely agreeing human basophils. However, relatively high concentrations, especially of fMLP, are required. For example, Eosinopenia Caused by Chemotaxins ofAcute Inflammatio 121269 0.1 mM fMLP is required to cause mast cell degranulation. Yet 2 nM fMLP causes stimulation of neutrophil or eosinophil motility2 and a 0.2-nmol fMLP injection into rabbits with blood volumes of roughly 100 ml caused eosinopenia. Thus the concentration of fMLP which caused eosinopenia was roughly 10-5 times that reported to cause basophil degranulation. Nevertheless, it must be noted that a brief, mild eosinopenia has been reported after antigen stimulation of allergic patients (30, 31) . The mechanisms of these in vivo responses are unknown but could involve release of eosinophil chemotaxins such as ECF-A (32) or histamine (33) . Also injections of large doses of histamine into dogs (34) or horses (35) has been reported to cause eosinopenia. Nevertheless, injection of physiologic doses of histamine or the ECF-A peptide, Val-Gly-Ser-Glu, did not produce an eosinopenic response which was any greater than that observed after injection of PBS. These data strongly suggest that the eosinopenic responses observed were not caused by mast cell degranulation.
The relevance of these eosinopenic responses to the eosinopenia of acute inflammation is obviously somewhat conjectural and requires further definition. Nevertheless, the rapid and prolonged eosinopenia produced by these chemotaxins of acute infection suggest that such reactions may contribute to development of the initial rapid eosinopenia that accompanies acute inflammation.
